Department of Health and Human Services August 23, 2007 – Federal Register Recent Federal Regulation Documents
Results 1 - 3 of 3
Supplementary Risk Assessments and Site Suitability Analyses for the National Emerging Infectious Disease Laboratory, Boston University Medical Center
The National Institutes of Health (NIH) has placed in the docket for public review and comment the Supplementary Risk Assessments and Site Suitability Analyses for the National Emerging Infectious Disease Laboratory, Boston University Medical Center, which address additional concerns of the local community regarding possible impacts of the National Emerging Infectious Diseases Laboratory, Boston University Medical Center. The purpose of the Supplementary Risk Assessments and Site Suitability Analyses for the National Emerging Infectious Disease Laboratory was alternative site analysis and risk assessment that investigated potential infectious disease threats that may be posed to the public should an exotic infectious agent be released into the community through an infected laboratory worker, laboratory accident, or other mishap.
Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
